MANAGING MYOPIA

A Clinical Response to the Growing Epidemic

WHAT IS MYOPIA?

Myopia is a chronic, progressive disease characterized by excessive eye elongation, risk of associated sight-threatening complications, and a negative-powered refractive error.1-4

GROWING GLOBAL EPIDEMIC

  • Reports of increased myopia prevalence in children first emerged in Asia in the 1980s.5,6
  • The number of people with myopia has nearly doubled within the past 20 years in both Eastern and Western Societies7
  • Prevalence among young adults is reported to be above 80% in many Asian regions,8 and 50% in the U.S. and parts of Europe9,10
  • Children in the first wave of high myopia prevalence (those born after 1970) are now on the cusp of experiencing sight-threatening complications as adults11-14

NO SAFE LEVEL OF MYOPIA2

  • The elongated eye is susceptible to pathological complications with significant risks to eye health and vision13,14
  • Any degree of myopia increases the risk of sight-threatening complications, with some complications leading to blindness in adulthood2,15
  • Each diopter increase in myopia results in 67% increased risk of myopic macular degeneration (MMD)16

Any degree of myopia increases the risk of sight-threatening complications.

CONTROLLING MYOPIA PROGRESSION image

MANAGING MYOPIA PROGRESSION

  • Eye-care practitioners now have the opportunity to slow myopia progression rather than just correct the visual symptoms17
  • Increased time outdoors can delay myopia onset18 and may slow its progression19
  • Several myopia-control therapies have shown efficacy of over 0.3 mm (around 0.75 D) over two to three years of treatment20-23

IN PRACTICE